JUVE Patent
About Martin Grund
Martin has been practicing as a European Patent Attorney and European Trademark & Design Attorney since 1999 and a German Patent Attorney since 1997, and is the founding member of Grund IP Group, which is a boutique intellectual property practice that opened its doors in January, 2006.
Martin began his patent career in 1994 at the Dr. Volker Vossius Law Firm in Munich, Germany, where he eventually became Partner and leader of the firm’s biotechnology patent group from 2001 through the end of 2005. He also had the opportunity to represent before the German Supreme Court (BGH) and the European Court of Justice in a contentious case relating to the patenting of human embryonic stem cells (case C-34/10, Oliver Bruestle v Greenpeace e.V, decided 18 October 2011).
In addition to his duties at Grund IP Group, Martin is a lecturer for the TÜV-Akademie biotechnology education series and for the “International & Comparative Intellectual Property Law” annual summer program (Munich, Germany) sponsored by the Santa Clara University School of Law, and directed by world-renowned copyright expert Professor Tyler Ochoa.
Martin Grund
GRUND IP GROUP
Steinsdorfstrasse 2
80538 Munich
Germany
+49 895480190
grund@grundipg.com
5 Specialisms
- Biotechnology
- Chemistry
- Pharmaceuticals
- Medical Devices
- Food Chemistry
Awards
- Ranked in JUVE Patent Filing
Publications
- Grund, Dr. Martin and Farmer, Dr. Stacey J. (2011) „The EU Stem Cell Debate: Can Patenting Stem Cell Innovations be Done Morally?“, Case C34/10 Brüstle v. Greenpeace – AG Bot’s Opinion, Bio-Science Law Review, Vol. 11, Issue 6, pp. 187-192.
- Grund, Dr. Martin (2011) „EuGH verbietet Patentierung von humanen embryonalen Stammzellen“ (ECJU forbids the patenting of human embryonic stem cells), BIOspektrum, Vol. 17, Issue 7, p. 832.
- Grund, Dr. Martin (2011) „Anmerkungen zum Urteil C-34/10 des EuGH über die Auslegung in Bezug auf die Biopatentrichtlinie und embryonale Stammzellen in der Sache Brüstle v. Greenpeace“, Mitteilungen der Patentanwälte, pp. 514- 515.
- Grund, Dr. Martin and Farmer, Dr. Stacey J. (2012) „Brüstle v Greenpeace: The End of The Road for Human Embryonic Stem Cell Patents“, Bio-Science Law Review, Vol. 12, Issue 2.
- Grund and Schleef (2013) „Minicircle Patents: A Short IP Overview of Optimizing Nonviral DNA Vectors“, Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, Germany.
- Farmer and Grund (2013) „Neural Precusor Cells II: Decision of the German Supreme Court X ZR 58/07 Brüstle /Greenpeace“, Bio-Science Law Review, Vol. 13, Issue 1.
- Farmer and Grund, Patentability of Vaccines (2014), Springer, Molecular Vaccines, Vol. 2.
- Mester, Farmer and Grund (2017) „EPO Enlarged Board of Appeal Decision G 1/15: Poisonous Divisionals Detoxified“, Bio-Science Law Review, Vol. 16, Issue 1.
- Eichner, Dr. Alexander and Grund, Dr. Martin (2019) „Patentability of Plants Obtained by Essentially Biological Processes: Decision T 1063/18 and the Subsequent Referral to the Enlarged Board of Appeal by the President of the EPO (G3.19)“, Bio-Science Law Review, Vol. 17, Issue 2, pp. 59-60.
- Grund, Dr. Martin, Farmer, Dr. Stacey J. and Schraml, Dr. Laura (2020) „The German constitutional court says „nein“ to the UPC“, Bio-Science Law Review, Vol. 18.